Targacept, Inc. (TRGT) to Report Second Quarter 2012 Financial Results on August 7, 2012  
7/31/2012 10:05:58 AM

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it will report financial results for the second quarter of 2012 on Tuesday, August 7, 2012, after the U.S. financial markets close.